310 related articles for article (PubMed ID: 15803642)
41. [Implantable cardioventer defibrillator in the treatment of malignant ventricular arrhythmias and its short-term follow-up].
Liu QM; Zhang Y; Zhou SH
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):179-80. PubMed ID: 12575357
[No Abstract] [Full Text] [Related]
42. Inappropriate sensing of pectoral myopotentials by an implantable cardioverter defibrillator system.
Karanam S; John RM
Pacing Clin Electrophysiol; 2004 May; 27(5):688-9. PubMed ID: 15125734
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
Nagra B; Awan MU; Miriyala V; Kantharia BK
Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
[No Abstract] [Full Text] [Related]
44. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
45. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
46. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
Van Gelder BM; Meijer A; Dekker LR; Bracke FA
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
[TBL] [Abstract][Full Text] [Related]
47. Shocking truths about implantable cardioverter defibrillator monitoring zones.
Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
[TBL] [Abstract][Full Text] [Related]
48. Troubleshooting implantable cardioverter-defibrillator related problems.
van Erven L; Schalij MJ
Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
[No Abstract] [Full Text] [Related]
49. Multiple inappropriate defibrillator discharges due to Twiddler's syndrome.
Asbach S; Brunner M; Zehender M; Bode C; Faber TS
Wien Klin Wochenschr; 2005 Dec; 117(23-24):801. PubMed ID: 16437315
[No Abstract] [Full Text] [Related]
50. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
Moore DR; Kok LC; Vijayaraman P
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
[No Abstract] [Full Text] [Related]
51. A worrisome experience during testing of an implantable cardioverter defibrillator (ICD).
Warren J; Elliott L; Perschbacher D
J Cardiovasc Electrophysiol; 2001 May; 12(5):619-21. PubMed ID: 11386530
[No Abstract] [Full Text] [Related]
52. A worrisome experience during testing of an implantable cardioverter defibrillator (ICD).
Viskin S
J Cardiovasc Electrophysiol; 2001 May; 12(5):619. PubMed ID: 11386529
[No Abstract] [Full Text] [Related]
53. Detection of refrigerator-associated 60 Hz alternating current as ventricular fibrillation by an implantable defibrillator.
Al Khadra AS; Al Jutaily A; Al Shuhri S
Europace; 2006 Mar; 8(3):175-7. PubMed ID: 16627434
[TBL] [Abstract][Full Text] [Related]
54. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
Maisel WH
Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
[No Abstract] [Full Text] [Related]
55. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
[TBL] [Abstract][Full Text] [Related]
56. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
[TBL] [Abstract][Full Text] [Related]
57. [How does it function? Implantable cardioverter-defibrillator (ICD)].
Steinbigler P; Haberl R
MMW Fortschr Med; 2004 Feb; 146(8):56-7. PubMed ID: 15346939
[No Abstract] [Full Text] [Related]
58. A comprehensive approach to management of ventricular arrhythmias.
Kusumoto F
Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
[TBL] [Abstract][Full Text] [Related]
59. [How do we treat an electrical storm in implantable cardioverter defibrillator (ICD) appropriate patients?].
Özin B
Turk Kardiyol Dern Ars; 2014 Jun; 42(4):417. PubMed ID: 25112002
[No Abstract] [Full Text] [Related]
60. [Failure in the functioning of an implanted automatic defibrillator due to pneumothorax occurring during its implantation ].
Navarro-Martínez J; Barrera E; Trillo L; Martí J; Delclós J; Escolano F
Rev Esp Anestesiol Reanim; 2002 May; 49(5):268-71. PubMed ID: 12216510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
